[Upcoming Webinar] Navigating Access to Therapies Once Approved

Event Details

[Upcoming Webinar] Navigating Access to Therapies Once Approved

Time: September 29, 2016 from 1pm to 2pm
Location: Online Webinar - Eastern Time Zone
Website or Map: http://www.readytalk.com/
Phone: 1.866.740.1260 -- Access code: 9449985
Event Type: webinar
Organized By: PPMD
Latest Activity: Sep 29, 2016

Export to Outlook or iCal (.ics)

Event Description

Thursday, September 29th at 1pm ET

With last week’s long-awaited and historic accelerated approval of Exondys 51 and other potential therapies currently in review and in late stages of development, the prospect of navigating multiple health insurance plans and patient assistance programs may feel daunting. PPMD continues to work towards broad access for our community and is committed to helping you master these new and complex systems.


Join us Thursday, September 29th at 1pm ET for the first in an ongoing informational webinar series to help empower you with tangible action items and resources to prepare for therapy access.


This webinar is appropriate for ALL members of our community, regardless of whether you are eligible for Exondys 51 or not.



  • Annie Kennedy, Parent Project Muscular Dystrophy
  • Timothy Franson, MD, YourEncore
  • David R. Zook, FaegreBD Consulting

To Participate:

  1. Visit ReadyTalk.com and use participant code 9449985. (Be sure to test your computer beforehand)
  2. Audio Dial-In Information:
    • U.S. & Canada: Dial 1.866.740.1260 and use the Access Code 9449985
    • Outside the U.S. and Canada: Lookup your number

Submit Questions:

Please submit questions in advance to info@parentprojectmd.org (subject line: Therapy Access Webinar) by Wednesday, September 28 at 12pm eastern.

Comment Wall


RSVP for [Upcoming Webinar] Navigating Access to Therapies Once Approved to add comments!

Join PPMD Community

Attending (6)

Not Attending (1)

Need help using this community site? Visit Ning's Help Page.



© 2021   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service